Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast

被引:13
作者
Li, Cheng-Jun [1 ]
Wang, Yi-Kai [2 ]
Zhang, Shun-Ming [3 ]
Ren, Mu-Dan [1 ]
He, Shui-Xiang [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gastroenterol, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Infect Dis, Xian 710004, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian 710061, Shaanxi, Peoples R China
关键词
Inflammatory bowel disease; Incidence; Average annual percentage change; Age-standardized rates; Prevalence trends; Global Burden of Disease; ENVIRONMENTAL RISK-FACTORS; CROHNS-DISEASE; IBD; CANCER;
D O I
10.3748/wjg.v29.i42.5751
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUNDInflammatory bowel disease (IBD) is an idiopathic intestinal disease with various levels and trends in different countries and regions. Understanding the current burden and trends of IBD in various geographical locations is essential to establish effective strategies for prevention and treatment. We report the average annual percentage change (AAPC) and estimated annual percentage change (EAPC) in age-standardized rates (ASR) of IBD in different regions based on the Global Burden of Disease (GBD) study from 1990-2019, and the relationships between IBD and the human development index (HDI) and socio-demographic index (SDI). The prevalence trends of IBD were predicted by gender from 2019-2039.AIMTo comprehensively investigate IBD data, providing further insights into the management of this chronic disease.METHODSWe collected the information on the incidence of IBD from the GBD study from 1990-2019 to calculate the AAPC and EAPC in ASR of IBD in different regions. The relationships between IBD, HDI, and SDI were analyzed. The Nordpred and Bayesian age-period-cohort models were used to predict the prevalence trends of IBD by gender from 2019-2039, and the reliability of the results was validated. Statistics of all the data in this study were performed using R software (version 4.2.1).RESULTSNorth America consistently had the highest IBD ASR, while Oceania consistently had the lowest. East Asia had the fastest average annual growth in ASR (2.54%), whereas Central Europe had the fastest decline (1.38%). Countries with a low age-standardized incidence rates in 1990 showed faster growth in IBD while there was no significant correlation in 2019. Additionally, IBD increased faster in countries with a low age-standardized death rates in 1990, whereas the opposite was true in 2019. Analysis of SDI and IBD ASR showed that countries with a high SDI generally had a higher IBD ASR. Finally, the projections showed a declining trend in the incidence of IBD from 2019-2039, but a gradual increase in the number of cases.CONCLUSIONAs the global population increases and ages, early monitoring and prevention of IBD is important to reduce the disease burden, especially in countries with a high incidence of IBD.
引用
收藏
页码:5751 / 5767
页数:17
相关论文
共 48 条
  • [1] Microbiota activation and regulation of innate and adaptive immunity
    Alexander, Katie L.
    Targan, Stephan R.
    Elson, Charles O., III
    [J]. IMMUNOLOGICAL REVIEWS, 2014, 260 (01) : 206 - 220
  • [2] Environmental Risk Factors for Inflammatory Bowel Diseases: A Review
    Ananthakrishnan, Ashwin N.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (02) : 290 - 298
  • [3] A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative Colitis
    Ananthakrishnan, Ashwin N.
    Khalili, Hamed
    Konijeti, Gauree G.
    Higuchi, Leslie M.
    De Silva, Punyanganie
    Korzenik, Joshua R.
    Fuchs, Charles S.
    Willett, Walter C.
    Richter, James M.
    Chan, Andrew T.
    [J]. GASTROENTEROLOGY, 2013, 145 (05) : 970 - 977
  • [4] Comorbidities in inflammatory bowel disease: a call for action
    Argollo, Marjorie
    Gilardi, Daniel
    Peyrin-Biroulet, Carina
    Chabot, Jean Francois
    Peyrin-Biroulet, Laurent
    Donese, Silvio
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (08): : 643 - 654
  • [5] Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
    Axelrad, Jordan E.
    Lichtiger, Simon
    Yajnik, Vijay
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (20) : 4794 - 4801
  • [6] Predictors and risks for death in a population-based study of persons with IBD in Manitoba
    Bernstein, Charles N.
    Nugent, Zoann
    Targownik, Laura E.
    Singh, Harminder
    Lix, Lisa M.
    [J]. GUT, 2015, 64 (09) : 1403 - 1411
  • [7] Bernstein CN, 2001, AM J GASTROENTEROL, V96, P2117, DOI 10.1111/j.1572-0241.2001.03946.x
  • [8] Mortality Trends in Crohn's Disease and Ulcerative Colitis: A Population-based Study in Quebec, Canada
    Bitton, Alain
    Vutcovici, Maria
    Sewitch, Maida
    Suissa, Samy
    Brassard, Paul
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (02) : 416 - 423
  • [9] Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
    Catalan-Serra, Ignacio
    Brenna, Oystein
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (11) : 2597 - 2611
  • [10] Coward S, 2019, J CAN ASSOC GASTROEN, V2, P56, DOI [10.1093/jcag/gwz006.028, DOI 10.1093/JCAG/GWZ006.028]